These results therefore clearly indicated that downregulation of FGD5-AS1 had significantly anti-tumor effects on gastric cancer proliferation (both in vitro and in vivo) and chemoresistance response to 5-FU. This evidence concerns the gene FGD5 and gastric cancer.